Article info
Review
Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis
- Correspondence to Sytske Anne Bergstra, Department of Rheumatology, Leiden University Medical Center, Leiden, 2333 ZA, Netherlands; s.a.bergstra{at}lumc.nl
Citation
Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis
Publication history
- Received September 15, 2022
- Accepted October 25, 2022
- First published November 21, 2022.
Online issue publication
March 31, 2023
Article Versions
- Previous version (3 January 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.